Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia. (Q34605266)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11960331%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

review article

1 reference

title

Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11960331%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

main subject

chronic myeloid leukemia

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11960331%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

Jiang X

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11960331%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Drummond MW

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11960331%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Eaves AC

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11960331%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Eaves CJ

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11960331%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 April 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11960331%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11960331%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11960331%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11960331%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

549-558

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11960331%20AND%20SRC:MED&resulttype=core&format=json

Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Fused transcript of abl and bcr genes in chronic myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Acute leukaemia in bcr/abl transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Direct evidence for presence of Ph-1 chromosome in erythroid cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Cytogenetic studies on bone-marrow in chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Involvement of the B-lymphoid system in chronic myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Philadelphia chromosome positive blood B lymphocytes in chronic myelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Defective regulation of leukemic hematopoiesis in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association with up-regulation of expression of interleukin-3

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

PERSISTENT MITOSIS OF TRANSFUSED HOMOLOGOUS LEUKOCYTES IN CHILDREN RECEIVING ANTILEUKEMIC THERAPY

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Complication of bone-marrow transplantation. Graft-versus-host disease resulting from chronic-myelogenous-leukaemia leucocyte transfusions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

The fluctuating phenotype of the lymphohematopoietic stem cell with cell cycle transit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Intensive combination chemotherapy (ROAP 10) and splenectomy in the management of chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Relapse of chronic myeloid leukaemia 14 years after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Structure and function of telomeres

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Telomere shortening and tumor formation by mouse cells lacking telomerase RNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Essential role of mouse telomerase in highly proliferative organs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

A survey of telomerase activity in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Regulation of telomere length and telomerase in T and B cells: a mechanism for maintaining replicative potential

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Absence of cancer-associated changes in human fibroblasts immortalized with telomerase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Extension of life-span by introduction of telomerase into normal human cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Telomere length shortening is associated with disease evolution in chronic myelogenous leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Evolution of bone marrow transplantation--the original immunotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Alpha1-acid glycoprotein expressed in the plasma of chronic myeloid leukemia patients does not mediate significant in vitro resistance to STI571.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

BCR-ABL accelerates C2-ceramide-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Autonomous multi-lineage differentiation in vitro of primitive CD34+ cells from patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Retrovirus-mediated transfer and expression of the interleukin-3 gene in mouse hematopoietic cells result in a myeloproliferative disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Targeted in vivo infection with a retroviral vector carrying the interleukin-3 (multi-CSF) gene leads to immortalization and leukemic transformation of primitive hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Selective differentiation and proliferation of hematopoietic cells induced by recombinant human interleukins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Control of granulocytes and macrophages: molecular, cellular, and clinical aspects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402444

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2402444

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11960331%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

9 December 2019

1016671327

0 references

1 reference